About Syschem (India) Limited
Data last updated:
Syschem (India) Limited is a public limited company based in Haryana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 31 December 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN L24219HR1993PLC032195. The company has 1 GST registration on record, which is no longer active. It is a listed company as per MCA records. Its shares are listed on BSE: 531173.
The company has an authorised share capital of ₹62 Cr and a paid-up capital of ₹53.62 Cr. It was formerly known as Anil Pesticides Ltd. It is led by directors including Ranjan Jain (Managing Director) and Suninder Veer Singh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 04 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Vill – Bargodamtehsil – Kalka Dist Panchkula, Haryana, India.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹573.77 Cr, a growth of 48.6% compared to the previous year. For the same year it recorded a net profit of ₹10.94 Cr (net margin 1.9%) and EBITDA of ₹21.1 Cr (EBITDA margin 3.7%). The net worth stands at ₹122.43 Cr (up 34.1% YoY). Total assets are valued at ₹125.33 Cr (up 34.5% YoY).
The company has about 110 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Syschem India. As per MCA filings, the company has open charges of ₹50.4 Cr and satisfied charges of ₹31.53 Cr on record. Court records list 106 cases involving the company, including 12 filed by the company and 94 filed against it; 5 cases are pending. The company has 21 deals on record (18 market trades, 3 funding rounds), with disclosed funding of ₹36.75 Cr; the latest was in December 2023. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Gland Chemicals Pvt Ltd with revenue of ₹401.18 Cr. The company has 11 MSME Form 1 returns on record between 2020 and 2024, listing 300 overdue payments to 37 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website syschem.in.
Company details
CIN history
Syschem (India) has one previous CIN (Corporate Identification Number): U24219HR1993PLC032195. The current CIN is L24219HR1993PLC032195, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24219HR1993PLC032195 | Current |
| U24219HR1993PLC032195 | Previous |
Contact details
Syschem (India) Limited's registered office is in Haryana. Its website is syschem.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVill – Bargodamtehsil – Kalka Dist Panchkula, Haryana, India
- IndustryPharma, API Manufacturers
To see the full contact details of Syschem (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Syschem (India) operates one associated brand: Syschem India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Contract manufacturer for APIs and bulk drugs | syschem.in |
Business activity
The main business activity of Syschem (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Syschem (India) Limited, buy the company report.
Financials of Syschem (India) Limited
FY 2025-26 filings availableSyschem (India) Limited reported revenue of ₹573.77 Cr (up 48.6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 574 | 386 | 233 | 130 | 65.63 | 74.41 | 76.93 |
| Revenue growth | +48.6% | +65.4% | +79.1% | +98.7% | -11.8% | -3.3% | - |
| EBITDA | 21.10 | 3.98 | 6.98 | 8.65 | 0.56 | (5.17) | (0.11) |
| EBITDA margin | +3.7% | +1.0% | +3.0% | +6.6% | +0.9% | -7.0% | -0.1% |
| Profit before tax | 14.80 | 1.00 | 4.11 | 6.16 | (2.17) | (7.32) | (2.19) |
| Net profit | 10.94 | 0.45 | 2.76 | 4.52 | (1.70) | (5.29) | (1.81) |
| Net profit margin | +1.9% | +0.1% | +1.2% | +3.5% | -2.6% | -7.1% | -2.4% |
| EPS (₹) | 1.93 | 0.11 | 0.69 | 1.42 | (0.73) | (2.58) | (0.99) |
| Balance sheet | |||||||
| Total assets | 125 | 93.21 | 67.26 | 49.74 | 34.27 | 38.93 | 26.47 |
| Net worth | 122 | 91.28 | 56.95 | 22.30 | 6.94 | 7.12 | 10.01 |
| Total debt | 0.40 | 0.00 | 0.45 | 1.61 | 1.75 | 15.21 | 16.45 |
| Cash & bank | 9.44 | 2.14 | 0.10 | 0.66 | 0.37 | 1.42 | 0.16 |
| Net working capital | 55.62 | 37.38 | 29.58 | 15.59 | (2.00) | 3.90 | (4.87) |
| Cash flow | |||||||
| Cash from operations | 7.59 | (10.09) | (25.65) | (8.49) | 1.07 | 3.72 | 3.46 |
| Cash from investing | (19.57) | (21.67) | (6.46) | (1.65) | (0.78) | (3.77) | (3.62) |
| Cash from financing | 17.95 | 33.81 | 31.64 | 10.69 | (0.28) | (0.06) | (0.02) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 109 | 219 | 142 | 104 | 109 | 119 | 77.76 | 47.52 |
| Revenue growth (YoY) | -0.1% | +84.5% | +82.0% | +118.0% | +24.9% | - | - | - |
| Other income | 0.05 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 |
| Total expenses | 109 | 210 | 136 | 100 | 107 | 117 | 76.56 | 47.45 |
| EBITDA | 0.55 | 9.36 | 5.97 | 3.30 | 2.47 | 1.90 | 1.20 | 0.07 |
| EBITDA margin | +0.5% | +4.3% | +4.2% | +3.2% | +2.3% | +1.6% | +1.5% | +0.1% |
| Depreciation | 1.56 | 1.73 | 0.82 | 0.76 | 0.76 | 0.91 | 0.68 | 0.68 |
| Interest | 0.49 | 2.04 | 0.17 | 0.01 | 0.04 | 0.00 | 0.04 | 0.03 |
| Profit before tax | (1.45) | 5.59 | 4.98 | 2.54 | 1.68 | 1.01 | 0.50 | (0.64) |
| Tax | 0.22 | 3.86 | 0.79 | 0.65 | 0.00 | 0.55 | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 109 | 219 | 142 | 104 | 109 | 119 | 77.76 | 47.52 |
| Revenue growth (YoY) | -0.1% | +84.5% | +82.0% | +118.0% | +24.9% | - | - | - |
| Other income | 0.05 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 |
| Total expenses | 109 | 210 | 136 | 100 | 107 | 117 | 76.56 | 47.45 |
| EBITDA | 0.55 | 9.36 | 5.97 | 3.30 | 2.47 | 1.90 | 1.20 | 0.07 |
| EBITDA margin | +0.5% | +4.3% | +4.2% | +3.2% | +2.3% | +1.6% | +1.5% | +0.1% |
| Depreciation | 1.56 | 1.73 | 0.82 | 0.76 | 0.76 | 0.91 | 0.68 | 0.68 |
| Interest | 0.49 | 2.04 | 0.17 | 0.01 | 0.04 | 0.00 | 0.04 | 0.03 |
| Profit before tax | (1.45) | 5.59 | 4.98 | 2.54 | 1.68 | 1.01 | 0.50 | (0.64) |
| Tax | 0.22 | 3.86 | 0.79 | 0.65 | 0.00 | 0.55 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 574 | 386 | 233 | 130 | 65.63 | 74.41 | 76.93 |
| Revenue growth | +48.6% | +65.4% | +79.1% | +98.7% | -11.8% | -3.3% | - |
| Other income | 0.02 | 0.04 | 0.17 | 0.25 | 0.13 | 0.26 | 0.09 |
| Total expenses | 553 | 382 | 226 | 122 | 65.07 | 79.58 | 77.04 |
| Employee cost | 0.00 | 8.25 | 6.08 | 4.40 | 4.54 | 4.10 | 2.99 |
| EBITDA | 21.10 | 3.98 | 6.98 | 8.65 | 0.56 | (5.17) | (0.11) |
| EBITDA margin | +3.7% | +1.0% | +3.0% | +6.6% | +0.9% | -7.0% | -0.1% |
| Depreciation | 4.06 | 2.95 | 2.79 | 2.70 | 2.58 | 2.35 | 2.15 |
| Interest | 2.26 | 0.07 | 0.25 | 0.04 | 0.28 | 0.06 | 0.02 |
| Profit before tax | 14.80 | 1.00 | 4.11 | 6.16 | (2.17) | (7.32) | (2.19) |
| Tax | 3.86 | 0.55 | 1.35 | 1.64 | (0.47) | (1.75) | (0.35) |
| Net profit | 10.94 | 0.45 | 2.76 | 4.52 | (1.70) | (5.29) | (1.81) |
| Net profit margin | +1.9% | +0.1% | +1.2% | +3.5% | -2.6% | -7.1% | -2.4% |
| EPS (₹) | 1.93 | 0.11 | 0.69 | 1.42 | (0.73) | (2.58) | (0.99) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 49.01 | 43.51 | 39.86 | 31.89 | 23.29 | 22.54 | 19.79 |
| Reserves & surplus | 73.42 | 47.77 | 17.09 | (9.59) | (17.24) | (15.54) | (9.97) |
| Shareholders' funds (net worth) | 122 | 91.28 | 56.95 | 22.30 | 6.94 | 7.12 | 10.01 |
| Secured loans | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 12.17 | 12.21 |
| Unsecured loans | 0.00 | 0.00 | 0.45 | 1.61 | 1.75 | 3.04 | 4.24 |
| Total debt | 0.40 | 0.00 | 0.45 | 1.61 | 1.75 | 15.21 | 16.45 |
| Total liabilities | 125 | 93.21 | 67.26 | 49.74 | 34.27 | 38.93 | 26.47 |
| Assets | |||||||
| Gross block | 103 | 84.66 | 59.23 | 56.55 | 55.54 | 51.12 | 46.83 |
| Net block | 67.60 | 53.11 | 30.57 | 30.66 | 31.55 | 29.71 | 27.55 |
| Capital work in progress | 0.00 | 0.29 | 4.11 | 0.15 | 0.00 | 0.98 | 0.66 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 58.24 | 68.28 | 51.40 | 15.52 | 19.14 | 33.26 | 20.53 |
| Sundry debtors | 144 | 89.54 | 68.43 | 41.94 | 3.32 | 5.74 | 9.86 |
| Cash & bank balances | 9.44 | 2.14 | 0.10 | 0.66 | 0.37 | 1.42 | 0.16 |
| Loans & advances | 6.40 | 1.48 | 6.42 | 0.45 | 0.71 | 1.72 | 0.56 |
| Total current assets | 219 | 161 | 126 | 58.57 | 23.54 | 42.14 | 31.11 |
| Total current liabilities | 163 | 124 | 96.77 | 42.98 | 25.54 | 38.24 | 35.98 |
| Net working capital | 55.62 | 37.38 | 29.58 | 15.59 | (2.00) | 3.90 | (4.87) |
| Total assets | 125 | 93.21 | 67.26 | 49.74 | 34.27 | 38.93 | 26.47 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 2.14 | 0.10 | 0.57 | 0.03 | 0.02 | 0.14 | 0.32 |
| Net cash from operating activities | 7.59 | (10.09) | (25.65) | (8.49) | 1.07 | 3.72 | 3.46 |
| Net cash from investing activities | (19.57) | (21.67) | (6.46) | (1.65) | (0.78) | (3.77) | (3.62) |
| Net cash from financing activities | 17.95 | 33.81 | 31.64 | 10.69 | (0.28) | (0.06) | (0.02) |
| Net change in cash | 5.97 | 2.04 | (0.48) | 0.54 | 0.00 | (0.11) | (0.18) |
| Closing cash | 9.44 | 2.14 | 0.10 | 0.66 | 0.37 | 1.42 | 0.16 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +48.6% | +65.4% | +79.1% | +98.7% | -11.8% | -3.3% | - |
| EBITDA growth | +430.2% | -43.0% | -19.3% | +1444.6% | +110.8% | -4600.0% | - |
| PBT growth | +1380.0% | -75.7% | -33.3% | +9998.0% | +70.4% | -234.3% | - |
| Net income growth | +2331.1% | -83.7% | -38.9% | +365.9% | +67.9% | -192.3% | - |
| Revenue CAGR (3Y) | +63.9% | +80.5% | +46.4% | +19.2% | -11.0% | +3.8% | +83.1% |
| EBITDA CAGR (3Y) | +34.6% | +92.3% | - | - | -46.1% | - | +22.4% |
| Profitability & leverage | |||||||
| Net income margin | +1.9% | +0.1% | +1.2% | +3.5% | -2.6% | -7.5% | -2.4% |
| Return on capital employed | - | +1.2% | +6.1% | +12.7% | 0.0% | 0.0% | 0.0% |
| Return on net worth | - | +0.5% | +5.3% | +20.9% | 0.0% | 0.0% | 0.0% |
| Debt / equity | - | 0.00 | 0.03 | 0.11 | 1.21 | 1.85 | 1.41 |
| Long-term debt / equity | - | 0.00 | 0.03 | 0.11 | 1.02 | 1.54 | 1.21 |
| Interest cover | 13.26 | 6.80 | 5.97 | 0.67 | -13.86 | -0.80 | -0.88 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 5.37 | 4.03 | 2.33 | 1.23 | 1.52 | 1.94 |
| Inventory turnover | - | 6.45 | 6.98 | 7.52 | 2.50 | 2.77 | 3.98 |
| Debtors turnover | - | 4.89 | 4.23 | 5.76 | 14.49 | 9.54 | 11.54 |
| EPS (₹) | 1.93 | 0.11 | 0.69 | 1.42 | (0.73) | (2.58) | (0.99) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 20.98 | 14.29 | 6.99 | 2.60 | 2.79 | 4.69 |
To see the full year-wise statements and ratios of Syschem (India) Limited, buy the company report.
Board of directors of Syschem (India) Limited
Syschem (India) has 6 current directors and 22 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suninder Veer Singh | Whole-Time Director | 30 Dec 2016 | 9 Years 9 Months | Current |
| Ranjan Jain | Managing Director | 13 Jan 2015 | 11 Years 9 Months | Current |
| Arshdeep Kaur Also directs: Indo Farm Equipment Limited, Spray Engineering Devices Limited, Leeford Healthcare Limited and 1 more | Director | 02 Nov 2022 | 3 Years 11 Months | Current |
| Renu Rawat Also directs: Piccadily Sugar and Allied Industries Limited, JCBL Limited, JCBL Marrel Tippers Private Limited and 1 more | Director | 02 Nov 2022 | 3 Years 11 Months | Current |
| Sunil Kumar Bhasin | Director | 24 Mar 2025 | 1 Years 7 Months | Current |
| Madan Lal Aggarwal Also directs: WTL Garments Limited | Director | 08 Nov 2024 | 1 Years 11 Months | Current |
Peer comparison
Syschem (India) Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Syschem (India) Limitedthis company | ₹573.77 Cr (FY 2026) | ₹10.94 Cr | 1.9% | 48.6% | 110 | Haryana, India |
| Gland Chemicals Pvt Ltd | ₹401.18 Cr (FY 2022) | 33.0% | Hyderabad, Telangana, India | |||
| Emnar Pharma Private Limited | ₹394.57 Cr (FY 2024) | 1.0% | Sanath Nagar Hyderabad, Telangana, India | |||
| Astec Lifesciences Limited | ₹386.93 Cr (FY 2025) | -17.0% | Mumbai, Maharashtra, India | |||
| Tatva Chintan Pharma Chem Limited | ₹385.03 Cr (FY 2025) | -4.0% | Ankleshwar, Gujarat, India | |||
| Rajasthan Antibiotics Ltd | ₹383.3 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| MSN Organics Private Limited | ₹376.38 Cr (FY 2024) | 75.0% | Hyderabad, Telangana, India | |||
| Alchem International Private Limited | ₹371.17 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| M. J. Biopharm Private Limited | ₹367.26 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India |
To see the full peer comparison of Syschem (India) Limited, buy the company report.
Auditor
Syschem (India) Limited is audited by S T A V & CO for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S T A V & CO | FY 2025 | 024510C |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 60.90%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.20% and retail and other public shareholders hold 39.00%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 60.90% | 56.70% | 56.70% | 56.70% |
| Public | 39.10% | 43.30% | 43.30% | 43.30% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Mar 2026 | 101250534 | Hdfc Bank Limited | ₹39.91 Lakh | Open | |
| 24 Feb 2023 | 100701832 | Hdfc Bank Limited | ₹50 Cr | Open | |
| 31 Mar 2014 | 10495870 | Pkf Finance Limited | ₹55 Lakh | Satisfied | |
| 31 Oct 2012 | 10386391 | Intec Capital Limited | ₹45.83 Lakh | Satisfied | |
| 30 Oct 2012 | 10383439 | Punjab Kashmir Finance Ltd. | ₹1 Cr | Satisfied |
To see the full charge records of Syschem (India) Limited, buy the company report.
Total charge records: 13 View all charges
Deals & funding
Syschem (India) Limited has 21 deals on record (18 market trades, 3 funding rounds), with disclosed funding of ₹36.75 Cr; the latest was in December 2023.
Deals on record (5 of 21)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2023 | Market trade | ₹2.23 Cr | Seller: an individual |
| Dec 2023 | Market trade | ₹1.59 Cr | Seller: an individual |
| Jul 2023 | Funding round | ₹31.9 Cr | |
| Aug 2022 | Market trade | ₹1.41 Cr | Buyer: Negen Capital Services Private Limited |
| Jun 2022 | Market trade | ₹66 Lakh | Buyer: an individual |
To see the full deal history of Syschem (India) Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Syschem (India) Limited has 106 court cases on record: 12 filed by Syschem (India), 94 filed against it. 5 cases are pending and 101 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 91 | 84 | 5 |
| High courts | 13 | 8 | 0 |
| Supreme Court | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 106)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jalandhar, Punjab | Civil miscellaneous application | Filed against the company by PKF Finance Ltd | Disposed |
| District court, North West, Delhi | Civil suit | Filed against the company by Sunder Marketing Associates Pvt.Ltd | Disposed |
| District court, Panchkula, Haryana | Execution petition | Filed against the company by PKF Finance Limited. | Disposed |
| District court, Rupnagar, Punjab | Execution petition | Filed against the company by PKF Finance Ltd | Disposed |
| District court, South East, Delhi | Criminal case | Filed against the company by Intec Capital Ltd | Disposed |
To see the full case history of Syschem (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Syschem (India) Limited has 11 MSME Form 1 returns on record between 2020 and 2024, listing 300 overdue payments to 37 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 37)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Ammonia Supply Company | |||
| Ganpati Hardware & Mill Store | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Syschem (India) Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Syschem (India) Limited has a workforce of 110 employees on its EPFO records as of Sep 25, 2025, across 1 active EPFO establishment.
GST
Syschem (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Syschem (India) Limited, buy the company report.
Recent activity
Syschem (India) Limited has 47 board changes on record since 1994: 27 appointments and 20 cessations. The latest: Sunil Kumar Bhasin was appointed as Director on 24 Mar 2025.
68 earlier events are in the company report.
News
Frequently asked questions
Syschem (India) is an active public limited company based in Haryana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 31 December 1993 (33+ years old) and is registered under CIN L24219HR1993PLC032195. Listed on BSE: 531173.
Syschem (India) reported revenue of ₹573.77 Cr for FY 2025-26 (up 48.6% YoY) based on standalone financials.
Syschem (India) has 6 current directors:
- Ranjan Jain - Managing Director
- Suninder Veer Singh - Whole-Time Director
- Arshdeep Kaur - Director
- Renu Rawat - Director
- Sunil Kumar Bhasin - Director
- Madan Lal Aggarwal - Director
The latest financial statements of Syschem (India) on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 04 September 2025. Year-wise statements from 2015 are in the company report.
No. Syschem (India) has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Syschem (India) is L24219HR1993PLC032195. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Syschem (India) is a listed company as per MCA records. Its shares are listed on BSE (code: 531173).
Syschem (India) has 106 court cases on record: 12 filed by the company and 94 filed against it. 5 are pending. Most are in the district courts.
Syschem (India) was incorporated on 31 December 1993, making it 33+ years old. It is registered with the Registrar of Companies, Haryana.
Syschem (India) has 21 deals on record (18 market trades, 3 funding rounds), with disclosed funding of ₹36.75 Cr; the latest was in December 2023.
The peers of Syschem (India) by revenue are Gland Chemicals Pvt Ltd, Emnar Pharma Private Limited, Astec Lifesciences Limited, Tatva Chintan Pharma Chem Limited, Rajasthan Antibiotics Ltd and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sunil Kumar Bhasin was appointed as Director on 24 Mar 2025. Vivek Trehan ceased to be Director on 24 Mar 2025. Madan Lal Aggarwal was appointed as Director on 08 Nov 2024. Syschem (India) has 47 board changes on record in total.